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Updating and reﬁ ning estimates of typhoid fever burden for 
public health action
Eﬀ orts to estimate the global burden of typhoid 
fever can be traced to a meeting of the Pan American 
Health Organization in 1984 and publication of 
the outcome in 1986.1 Although an important ﬁ rst 
step, the 1984 study was recognised as having a 
number of limitations including provision of scanty 
methodological detail, the availability of few source 
data, exclusion of China from the estimate, and lack 
of consideration of the age distribution of typhoid 
fever. Subsequently the global typhoid burden was re-
estimated for the year 2000, accounting for growth 
of the global population, new typhoid fever incidence 
data from population-based studies and the control 
groups of vaccine trials, advances in the understanding 
of the age distribution of typhoid fever and its 
relation to force of infection, adjustment for blood 
culture sensitivity, and formalisation of methods for 
assessment of disease burden.2 Since 2000, an updated 
review of population-based studies of typhoid fever 
incidence and data from notiﬁ able disease reports 
from countries with advanced surveillance systems 
has been published.3 Incorporating these data, the 
Institute for Health Metrics and Evaluation (IHME) 
added their ﬁ rst estimate of disability and death 
associated with typhoid and paratyphoid fevers in 
aggregate to the Global Burden of Disease (GBD) 
2010 project.4,5 The IHME GBD 2010 estimate could 
be criticised for insuﬃ  cient methodological detail 
for external reproducibility, lack of disaggregation 
of typhoid and paratyphoid fevers, little description 
of the age distribution of disease, and the surprising 
selection of liver abscesses and cysts as the prime 
disease complication of interest.6
It is in this context that Vittal Mogasale and others 
revisit typhoid fever burden with an eye to reﬁ ning 
estimates to inform vaccine policy.7 Theirs is not a 
global estimate, although most typhoid fever cases 
do occur in countries classiﬁ ed in the low-income 
and middle-income group. Furthermore, with 
monovalent typhoid vaccines in mind, the focus 
is exclusively on Salmonella enterica serovar Typhi, 
with no estimate for Salmonella Paratyphi A or for 
invasive non-typhoidal Salmonella. The investigators 
did a series of well described systematic reviews 
to update and improve estimates of typhoid fever 
incidence, including age distribution, blood-culture 
sensitivity, and case-fatality ratio. They also take 
the innovative step of adding a risk-factor-based 
adjustment of typhoid fever incidence that accounts 
for lack of access to improved water in rural areas and 
in urban slums. This adjustment was derived from a 
further systematic review of case-control studies to 
ascertain the contribution of waterborne transmission 
to typhoid fever risk. In so doing, Mogasale and 
colleagues estimate that 11·9 million typhoid fever 
illnesses and 129 000 deaths occurred in low-income 
and middle-income countries 2010. These numbers 
are lower overall by almost half compared with earlier 
estimates,2 and suggest higher incidence in Africa 
and lower incidence in Asia than previously thought. 
Whether these diﬀ erences reﬂ ect true changes in 
typhoid fever epidemiology over time, methodological 
diﬀ erences, or both is diﬃ  cult to know.
Mogasale and colleagues highlight a number of limit-
ations. First, despite the growing number of studies 
on typhoid fever incidence, the amount of source data 
remains quite scarce. Furthermore, what constitutes 
a population-based study of typhoid fever incidence 
is open to inter pretation. Mogasale and others chose 
a fairly permissive interpretation to optimise the 
breadth of data. One consequence is the inclusion of 
a heterogeneous group of study types that are likely 
to vary considerably in the completeness of capture 
of cases. This can be problematic when seeking to 
understand typhoid fever incidence by age group, when 
diﬀ erences in detection by age could have substantial 
eﬀ ects on apparent age distribution. Indeed, the 
age distribution of cases derived from Mogasale and 
colleagues’ review diﬀ ers from that measured by very 
intensive active surveillance in a high incidence setting.8 
Second, although it is an important and biologically 
plausible reﬁ nement, risk-factor adjustment based 
on lack of access to improved water in rural areas and 
urban slums could be open to criticism, as the authors 
acknowledge. The imperfect relation between access to 
improved water and consumption of microbiologically 
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safe water is underscored by the occurrence of massive 
typhoid fever outbreaks in settings with water sources 
that would be classiﬁ ed as improved.9
Third, reliable estimates of typhoid fever 
complications and death remain elusive. Hospital-
based studies can be biased towards severe disease, yet 
the early detection and treatment of cases inherent and 
appropriate in high-quality populated-based disease 
surveillance systems undoubtedly modiﬁ es patients’ 
outcomes.10,11 Finally, it is important to ask how the 
results stack up against other sources of data. Few 
would question that typhoid fever has declined in a 
number of Asian countries.12 Furthermore, there have 
been increasing reports of high levels of endemic13,14 
and epidemic15,16 typhoid fever from some locations 
in Africa. However, studies of community-acquired 
bloodstream infections suggest that non-typhoidal 
Salmonella has been more common than typhoidal 
Salmonella in sub-Saharan Africa17 and national disease 
surveillance data do not seem consistent with the 
suggestion that South Africa is a country with a high 
incidence of typhoid fever.18 Indeed, as highlighted 
by Mogasale and colleagues, incidence estimates 
for sub-Saharan Africa are heavily inﬂ uenced by one 
population-based study from an urban slum in Nairobi, 
Kenya.13 The recently completed multicountry study of 
typhoid fever incidence in Africa should go some way to 
providing more data and addressing these concerns.19
Burden of disease estimates are foundational to 
building the investment case for both vaccine and non-
vaccine interventions for typhoid fever. Decisions about 
who would most beneﬁ t from vaccination and at what 
age rely on a clear epidemiological picture. Our picture 
of typhoid fever burden remains clouded, but Mogasale 
and colleagues have made reﬁ nements that challenge us 
to think more deeply and to value new data. Soon two 
new estimates of global typhoid and paratyphoid fever 
burden, from IHME GBD 201320 and the WHO Foodborne 
Diseases Burden Epidemiology Reference Group,21 will 
become available. The iterative process of reﬁ ning 
and updating burden estimates for typhoid fever is 
now occurring both consecutively and in parallel, with 
multiple groups working somewhat independently. 
Looking to the future, it might be time to take stock 
of existing estimates and methods, drawing from 
the strengths of each approach, and striving for both 
methods that are transparent and results that are 
timely. Typhoid control would beneﬁ t from collective 
eﬀ ort to ensure the best possible data to support policy 
decisions and from a clear message to the world on the 
scale of the problem.
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